肽名稱
|
CAS:號
|
中文名
|
序列
|
純度
|
分子量
|
分子式
|
庫存
|
作用
|
decapeptide-12
|
|
十肽-12
|
|
≥98%
|
1395.55
|
C65H90N18O17
|
0.12
|
淡化雀斑
|
Leuprorelin acetate
|
74381-53-6
|
醋酸亮丙瑞林
|
Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
|
≥98%
|
1209.41
|
C59H84N16O12
|
450
|
中--樞性性早熟,子宮肌瘤,子宮內(nèi)膜異位癥,前列腺癌、絕經(jīng)前乳腺癌
|
Alarelin Acetate
|
79561-22-1
|
醋酸阿拉瑞林
|
Glp-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt
|
≥98%
|
1167.3
|
C56H78N16O12
|
45
|
1.治療子宮內(nèi)膜異位癥。2.子宮肌瘤。3.性早熟。4.也可用于輔助生育技術(shù)。
|
TRH
|
24305-27-9
|
普羅瑞林
|
Glp-His-Pro-NH2
|
≥98%
|
362.38367
|
C16H22N6O4
|
8.5
|
甲狀腺疾病
|
Desmopressin Acetate
|
16789-98-3
|
醋酸去氨加壓素(DDAVP)
|
|
≥98%
|
1069.24
|
C46H64N14O12S2
|
13.5
|
中--樞性尿崩癥、夜間遺尿及血友病等,也用于腎尿液濃縮功能的測試。 也可用作術(shù)后止血。
|
Argpressin Acetate
|
113-79-1
|
醋酸精氨酸加壓素
|
H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
|
≥98%
|
1144.28
|
C48H69N15O14S2
|
150
|
預(yù)防或治療高血壓、雷氏綜合癥、痛經(jīng)、早產(chǎn)、促腎上腺皮質(zhì)激素釋放激素分泌紊亂、腎上腺增生、抑郁癥、慢性充血性心力衰竭、肝硬化、抗**激素分泌紊亂綜合癥或慢性心力衰竭/肝硬化/抗**激素分泌紊亂引起的低鈉血癥中有積極作用。
|
Felypressin Acetate
|
56-59-7
|
醋酸苯賴加壓素
|
Cys-Phe-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
|
≥98%
|
1040.22
|
C46H65N13O11S2
|
14
|
收縮外周血管、升高血壓及止血。
|
Lypressin Acetate
|
50-57-7
|
醋酸賴加壓素
|
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
|
≥98%
|
1056.22
|
C46H65N13O12S2
|
32
|
抗**和血管收縮
|
Terlipressin Acetate
|
14636-12-5
|
醋酸特利加壓素
|
|
≥98%
|
1227.37
|
C52H74N16O15S2
|
45
|
1.本品用于胃腸道和泌尿生殖系統(tǒng)的出血,如食道靜脈曲張、胃和十二指腸潰瘍、功能性及其它原因引起的子宮出血、生產(chǎn)和/或流產(chǎn)等等引起的出血的治療;2.用于手術(shù)后出血的治療,特別是腹腔和盆腔區(qū)域的出血;3.婦科手術(shù)的局部應(yīng)用,如在子宮頸。
|
Eptifibatide Acetate
|
148031-34-9
|
酸酸依非巴肽
|
Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2
|
≥98%
|
832.4
|
C35H49N11O9S2
|
19.6
|
冠脈綜合征病人
|
P191102-B005
|
69440-99-9
|
胸腺法新
|
|
≥98%
|
3108.28
|
C129H215N33O55
|
3
|
1.慢性乙型肝炎。2.作為免疫損害病者的疫苗免疫應(yīng)答增強(qiáng)劑。免疫系統(tǒng)功能受到抑制者,包括接受慢性血液透析和老年病患者,本品可增強(qiáng)病者對病毒性疫苗,例如流感疫苗或乙肝疫苗的免疫應(yīng)答。
|
Octreotide
|
83150-76-9
|
奧曲肽
|
|
≥98%
|
1019.28
|
C49H66N10O10S2
|
170
|
用于肢端肥大癥。肝硬化所致食管-胃靜脈曲張出血的緊急治療,與特殊治療(如內(nèi)窺鏡硬化劑治療)合用。預(yù)防胰腺術(shù)后并發(fā)癥。緩解與胃腸內(nèi)分泌腫瘤有關(guān)的癥狀和體征。
|
Teriparatide Acetate
|
52232-67-4
|
醋酸特立帕肽
|
H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
≥98%
|
4117.72
|
C181H291N55O51S2
|
9
|
特立帕肽刺激骨形成和骨吸收,可減少絕經(jīng)后婦女骨折的發(fā)生率,根據(jù)給藥--方式的不同,還能提高或降低骨密度。
|
Liraglutide
|
204656-20-2
|
利拉魯肽
|
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N-ε-(Nα-Palmitoyl-L-γ-glutamyl))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
|
≥98%
|
3751.2
|
C172H265N43O51
|
4.9
|
用于治療糖尿病或肥胖
|
Atosiban Acetate
|
90779-69-4
|
醋酸阿托西班
|
Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Cyclic1-6)
|
≥98%
|
994.199
|
C43H67N11O12S2
|
51
|
早產(chǎn),阿托西班是催產(chǎn)素和后葉加壓素受體拮抗劑, 用于推遲其即將出現(xiàn)的早產(chǎn)。
|
Bremelanotide Acetate
|
32780-32-8
|
醋酸布雷默浪丹
|
|
≥98%
|
1025.2
|
C50H68N14O10
|
160
|
|
Melanotan I
|
75921-69-6
|
醋酸美拉諾坦I
|
|
≥98%
|
|
C78H111N21O19
|
7
|
|
Melanotan Ⅱ
|
121062-08-6
|
醋酸美拉諾坦Ⅱ
|
AC-NLE-CYCLO(-ASP-HIS-D-PHE-ARG-TRP-LYS-NH2)
|
≥98%
|
1024.18
|
C50H69N15O9
|
40
|
|
BPC157
|
|
|
Gly-Glu-Pro-Pro-Pro-Gly- Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
|
≥98%
|
1419.53552
|
C62H98N16O22
|
120
|
|
DSIP
|
62568-57-4
|
依米地肽
|
TRP-ALA-GLY-GLY-ASN-ALA-SER-GLY-GLU
|
≥98%
|
848.81
|
|
17
|
促進(jìn)睡眠
|
Selank
|
129954-34-3
|
|
Thr-Lys-Pro-Arg-Pro-Gly-Pro
|
≥98%
|
|
C33H57N11O9
|
140
|
精神類藥物
|
FTPP (Fat Targeted Proapoptotic Peptide)
|
|
|
|
≥98%
|
|
|
10
|
|
ACTH (4-10)
|
780533
|
|
Met-Glu-His-Phe-Arg-Trp-Gly
|
≥98%
|
962.1
|
C44H59N13O10S1
|
8.8
|
|
Dermorphin
|
|
|
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2
|
≥98%
|
802.9
|
C40H50N8O10
|
38
|
|
Pinealon
|
|
|
|
≥98%
|
|
|
5
|
|
MOTS-c (Human)
|
121283-65-6
|
緩激肽
|
|
≥98%
|
|
|
22
|
|
|
|
|
Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg
|
|
|
|
|
|
|
|
|
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe
|
|
|
|
|
|
|
|
|
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu
|
|
|
|
|
|
|
|
|
Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg
|
|
|
|
|
|
|
|
|
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg
|
|
|
|
|
|
|
|
|
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Ser-Val-Gln-Val-Ser
|
|
|
|
|
|
|
|
|
Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
|
|
|
|
|
|
|
|
|
Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
|
|
|
|
|
|
PNC27 peptide
|
|
|
PPLSQETFSDLWKLL
|
≥98%
|
1772.93
|
C84H128N18O24
|
16.5
|
|
Flag tag peptide
|
|
|
DYKDDDDK
|
≥98%
|
|
|
36.6
|
|
LL-37
|
154947-66-7
|
|
H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH
|
≥98%
|
4493.33
|
C205H340N60O53
|
48.98
|
|
MOG35-55
|
149635-73-4
|
|
H-MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS-OH
|
≥98%
|
2581.99
|
C118H177N35O29S
|
12
|
|